Ramiro Sanchez - Net Worth and Insider Trading
Ramiro Sanchez Net Worth
The estimated net worth of Ramiro Sanchez is at least $659,698 dollars as of 2024-11-29. Ramiro Sanchez is the Chief Medical Officer of Cerevel Therapeutics Holdings Inc and owns about 14,673 shares of Cerevel Therapeutics Holdings Inc (CERE) stock worth over $659,698. Details can be seen in Ramiro Sanchez's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ramiro Sanchez has not made any transactions after 2023-12-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ramiro Sanchez
Ramiro Sanchez Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ramiro Sanchez owns 1 companies in total, including Cerevel Therapeutics Holdings Inc (CERE) .
Click here to see the complete history of Ramiro Sanchez’s form 4 insider trades.
Insider Ownership Summary of Ramiro Sanchez
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CERE | Cerevel Therapeutics Holdings Inc | 2023-12-26 | Chief Medical Officer |
Ramiro Sanchez Latest Holdings Summary
Ramiro Sanchez currently owns a total of 1 stock. Ramiro Sanchez owns 14,673 shares of Cerevel Therapeutics Holdings Inc (CERE) as of December 26, 2023, with a value of $659,698.
Latest Holdings of Ramiro Sanchez
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CERE | Cerevel Therapeutics Holdings Inc | 2023-12-26 | 14,673 | 44.96 | 659,698 |
Holding Weightings of Ramiro Sanchez
Ramiro Sanchez Form 4 Trading Tracker
According to the SEC Form 4 filings, Ramiro Sanchez has made a total of 4 transactions in Cerevel Therapeutics Holdings Inc (CERE) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Cerevel Therapeutics Holdings Inc is the sale of 10,000 shares on December 26, 2023, which brought Ramiro Sanchez around $424,700.
Insider Trading History of Ramiro Sanchez
- 1
Ramiro Sanchez Trading Performance
Ramiro Sanchez Ownership Network
Ramiro Sanchez Owned Company Details
What does Cerevel Therapeutics Holdings Inc do?
Who are the key executives at Cerevel Therapeutics Holdings Inc?
Ramiro Sanchez is the Chief Medical Officer of Cerevel Therapeutics Holdings Inc. Other key executives at Cerevel Therapeutics Holdings Inc include director & See Remarks N Anthony Coles , Chief Scientific Officer John Renger , and Chief Human Resources Officer Kenneth Dipietro .
Cerevel Therapeutics Holdings Inc (CERE) Insider Trades Summary
Over the past 18 months, Ramiro Sanchez made 4 insider transaction in Cerevel Therapeutics Holdings Inc (CERE) with a net sale of 37,652. Other recent insider transactions involving Cerevel Therapeutics Holdings Inc (CERE) include a net sale of 627,506 shares made by N Anthony Coles , a net sale of 24,572 shares made by Scott Akamine , and a net sale of 14,256 shares made by Kenneth Dipietro .
In summary, during the past 3 months, insiders sold 0 shares of Cerevel Therapeutics Holdings Inc (CERE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 966,157 shares of Cerevel Therapeutics Holdings Inc (CERE) were sold and 17,422,701 shares were bought by its insiders, resulting in a net purchase of 16,456,544 shares.
Cerevel Therapeutics Holdings Inc (CERE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cerevel Therapeutics Holdings Inc Insider Transactions
Ramiro Sanchez Mailing Address
Above is the net worth, insider trading, and ownership report for Ramiro Sanchez. You might contact Ramiro Sanchez via mailing address: C/o Cerevell Therapeutics Holdings Inc., 131 Dartmouth Street Suite 502, Boston Ma 02116.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
